Clinical Trial Update: Ciprofloxacin Compared to Placebo in Diagnosing Prostate Cancer in Patients Undergoing Prostate Biopsy [Phase 2]

View source ↗

Summary

The Phase 2 trial evaluating ciprofloxacin versus placebo to aid in diagnosing prostate cancer in men undergoing prostate biopsy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Ciprofloxacin (Ciprofloxacin hydrochloride)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Prostate Cancer | Phase 2 | Status: WITHDRAWN